84 related articles for article (PubMed ID: 1828358)
1. [Osteopathy and therapeutic effect of 1 alpha-OH-D3 in severely handicapped children].
Kimura A
No To Hattatsu; 1991 May; 23(3):265-72. PubMed ID: 1828358
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of bone atrophy by microdensitometry and effect of active vitamin D3 (1 alpha-OH-D3) administration in patients receiving anticonvulsants].
Takeno Y
No To Shinkei; 1989 Sep; 41(9):887-93. PubMed ID: 2511908
[TBL] [Abstract][Full Text] [Related]
3. Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsant medication.
Nishiyama S; Kuwahara T; Matsuda I
Eur J Pediatr; 1986 Feb; 144(5):457-63. PubMed ID: 3007152
[TBL] [Abstract][Full Text] [Related]
4. Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children.
Tolman KG; Jubiz W; Sannella JJ; Madsen JA; Belsey RE; Goldsmith RS; Freston JW
Pediatrics; 1975 Jul; 56(1):45-50. PubMed ID: 1161362
[TBL] [Abstract][Full Text] [Related]
5. [Microdensitometric study of maturation and fragility of the bone in male patients with cerebral palsy--the effect of long-term administration of 1 alpha-hydroxy vitamin D3 and the value of osteocalcin as a marker of bony growth].
Hayashi Y; Araki K; Morioka N; Kurashige T; Shiraishi T; Ogura H; Tani J
No To Hattatsu; 1990 May; 22(3):209-15. PubMed ID: 2363958
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D-dependency rickets in institutionalized, mentally retarded children on long term anticonvulsant therapy. II. The response to 25-hydroxycholecalciferol and to vitamin D2.
Maclaren N; Lifshitz F
Pediatr Res; 1973 Nov; 7(11):914-22. PubMed ID: 4356082
[No Abstract] [Full Text] [Related]
7. [Evaluation of anticonvulsant-induced bone changes by a microdensitometric method].
Iwata Y; Amano K; Kawamura H; Tanikawa T; Kawabatake H; Notani M; Iseki H; Shiwaku T; Nagao T; Taira T
No Shinkei Geka; 1985 Mar; 13(3):293-9. PubMed ID: 4010879
[TBL] [Abstract][Full Text] [Related]
8. Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs.
Jubiz W; Haussler MR; McCain TA; Tolman KG
J Clin Endocrinol Metab; 1977 Apr; 44(4):617-21. PubMed ID: 849976
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating levels of gamma-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy.
Takeshita N; Seino Y; Ishida H; Seino Y; Tanaka H; Tsutsumi C; Ogata K; Kiyohara K; Kato H; Nozawa M
Calcif Tissue Int; 1989 Feb; 44(2):80-5. PubMed ID: 2492894
[TBL] [Abstract][Full Text] [Related]
10. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D.
Davie MW; Emberson CE; Lawson DE; Roberts GE; Barnes JL; Barnes ND; Heeley AF
Q J Med; 1983; 52(205):79-91. PubMed ID: 6603629
[TBL] [Abstract][Full Text] [Related]
11. Long-term anticonvulsant therapy and vitamin D metabolism in ambulatory pubertal children.
Ala-Houhala M; Korpela R; Koivikko M; Koskinen T; Koskinen M; Koivula T
Neuropediatrics; 1986 Nov; 17(4):212-6. PubMed ID: 3100981
[TBL] [Abstract][Full Text] [Related]
12. Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy.
Pylypchuk G; Oreopoulos DG; Wilson DR; Harrison JE; McNeill KG; Meema HE; Ogilvie R; Sturtridge WC; Murray TM
Can Med Assoc J; 1978 Mar; 118(6):635-8. PubMed ID: 418865
[TBL] [Abstract][Full Text] [Related]
13. [Effects of alfacalcidol (1 alpha-OH-D3) on post oophorectomy osteopenia as measured by microdensitometry].
Ohta H; Nemoto K; Iizuka R
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):505-12. PubMed ID: 2754281
[TBL] [Abstract][Full Text] [Related]
14. Senile deafness and metabolic bone disease.
Yamazaki T; Ogawa K; Imoto T; Hayashi N; Kozaki H
Am J Otol; 1988 Sep; 9(5):376-82. PubMed ID: 3202126
[TBL] [Abstract][Full Text] [Related]
15. Hypocalcaemia and secondary hyperparathyroidism in institutionalised mentally-retarded patients receiving anticonvulsant drugs: a survey of 292 patients.
Maclay E; Hadden DR; McIlrath EM; Nesbitt GS
Ulster Med J; 1978; 47(1):63-72. PubMed ID: 653898
[No Abstract] [Full Text] [Related]
16. Bone status of children receiving anticonvulsant therapy.
Barden HS; Mazess RB; Chesney RW; Rose PG; Chun R
Metab Bone Dis Relat Res; 1982; 4(1):43-7. PubMed ID: 7121254
[TBL] [Abstract][Full Text] [Related]
17. Serum vitamin E concentration in patients with severe multiple handicaps treated with anticonvulsants.
Higashi A; Tamari H; Ikeda T; Ohtani Y; Matsukura M; Miyoshino S; Matsuda I
Pediatr Pharmacol (New York); 1980; 1(2):129-34. PubMed ID: 6213919
[TBL] [Abstract][Full Text] [Related]
18. Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy.
Morijiri Y; Sato T
Arch Dis Child; 1981 Jun; 56(6):446-9. PubMed ID: 6973324
[TBL] [Abstract][Full Text] [Related]
19. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
20. [Phosphorus-calcium metabolism and plasma 25-hydroxycholecalciferol in intestinal malabsorption].
Bozio AM; Paunier L; Nusslé D; Sizonenko PC
Helv Paediatr Acta; 1980 Sep; 35(4):313-23. PubMed ID: 7451235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
